Related Experiment Videos
Head circumference and incident Alzheimer's disease: modification by apolipoprotein E
A Borenstein Graves1, J A Mortimer, J D Bowen
1Department of Epidemiology and Biostatistics, University of South Florida, Tampa, 33612-3805, USA. amgraves@hsc.usf.edu
Neurology
|October 24, 2001
Summary
Smaller head circumference (HC) combined with the APOE epsilon 4 gene significantly increases the risk and hastens the onset of Alzheimer's disease (AD). This supports the brain reserve hypothesis in genetically predisposed individuals.
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- Alzheimer's disease (AD) clinical expression is linked to exceeding a critical threshold of "brain reserve."
- Head circumference (HC) serves as a proxy for brain reserve.
- The study investigates the association between HC, AD incidence, and APOE epsilon 4 genotype modification.
Purpose of the Study:
- To examine the relationship between head circumference (HC) and the incidence of probable Alzheimer's disease (AD).
- To assess the modifying effect of the APOE epsilon 4 genotype on the HC-AD association.
- To investigate the brain reserve hypothesis in the context of AD onset.
Main Methods:
- A cohort of 1,869 initially nondemented individuals followed for a mean of 3.8 years.
- Identified 59 incident cases of probable AD.
- Used Cox proportional hazard regression to analyze hazard ratios (HR) for HC and APOE epsilon 4, adjusting for covariates like age, education, and gender.
Main Results:
- Individuals with probable AD were older, less educated, shorter, lighter, and more likely to have APOE epsilon 4.
- The lowest tertile of HC showed a non-significant HR of 2.3 (p=0.16) after adjustments.
- APOE epsilon 4 significantly increased AD risk (HR=4.8, p=0.002).
- The combination of low HC and APOE epsilon 4 strongly predicted earlier AD onset (HR=14.1, p=0.0007).
Conclusions:
- Smaller head circumference (HC), particularly with the APOE epsilon 4 allele, accelerates the age of Alzheimer's disease (AD) onset.
- Findings support the brain reserve hypothesis, highlighting its role in AD manifestation.
- Genetic predisposition (APOE epsilon 4) interacts with brain reserve (HC) to influence clinical AD expression.